Common variants of ACE contribute to variable age-at-onset of Alzheimer’s disease

[1]  Patrick G. Kehoe,et al.  Review: The renin-angiotensin-aldosterone system and Alzheimer's disease? , 2003 .

[2]  L. Feuk,et al.  Haplotypes extending across ACE are associated with Alzheimer's disease. , 2003, Human molecular genetics.

[3]  Kaj Blennow,et al.  Cerebrospinal fluid levels of total‐tau, phospho‐tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment , 2003 .

[4]  L. Feuk,et al.  Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease , 2003, Human mutation.

[5]  A. Adeyemo,et al.  Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. , 2002, Human molecular genetics.

[6]  Rajesh Pahwa,et al.  Age at onset in two common neurodegenerative diseases is genetically controlled. , 2002, American journal of human genetics.

[7]  A. Igarashi,et al.  Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity* , 2001, The Journal of Biological Chemistry.

[8]  Lars Bertram,et al.  New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.

[9]  R C Elston,et al.  Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. , 2001, American journal of human genetics.

[10]  P. Amouyel,et al.  Genetic susceptibility factors for Alzheimer's disease. , 2001, European journal of pharmacology.

[11]  D. Selkoe.  The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins. , 2000, Neurologic clinics.

[12]  G. Abecasis,et al.  Pedigree tests of transmission disequilibrium , 2000, European Journal of Human Genetics.

[13]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[14]  K. Blennow,et al.  Prevalence and Incidence of Clinically Diagnosed Memory Impairments in a Geographically Defined General Population in Sweden , 1999, Neuroepidemiology.

[15]  M Farrall,et al.  Measured haplotype analysis of the angiotensin-I converting enzyme gene. , 1998, Human molecular genetics.

[16]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[17]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  N. Samani,et al.  A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. , 1996, Circulation.

[19]  D E Weeks,et al.  Polygenic disease: methods for mapping complex disease traits. , 1995, Trends in genetics : TIG.

[20]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[21]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[22]  G. Small.  Age at onset versus age at examination of Alzheimer-type dementia. , 1986, The American journal of psychiatry.

[23]  W. G. Hill,et al.  Estimation of linkage disequilibrium in randomly mating populations , 1974, Heredity.

[24]  Patrick G Kehoe,et al.  The renin-angiotensin-aldosterone system and Alzheimer s disease? , 2003, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[25]  Kaj Blennow,et al.  Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. , 2003, Acta neurologica Scandinavica. Supplementum.

[26]  G. Lathrop,et al.  High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity , 2002, European Journal of Human Genetics.

[27]  Zhaohui S. Qin,et al.  Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. , 2002, American journal of human genetics.

[28]  L. Feuk,et al.  Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. , 2001, Genome research.

[29]  K. Blennow,et al.  Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project. , 1999, Neuroepidemiology.

[30]  M. Owen,et al.  Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease , 1999, Nature Genetics.